Department of Medicine, NIHR Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, United Kingdom.
JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Sci Rep. 2018 Aug 13;8(1):12079. doi: 10.1038/s41598-018-30621-4.
Human T regulatory cells (T regs) express high levels of TNF receptor 2 (TNFR2). Ligation of TNFR2 with TNF, which can recognise both TNFR1 and TNFR2, or with a TNFR2-selective binding molecule, DARPin 18 (D18) activates canonical NF-κB signalling, assessed by IκBα degradation, and the magnitude of the response correlates with the level of TNFR2 expression. RNA-seq analysis of TNF- or D18-treated human T regs revealed that TNFR2 ligation induces transcription of NFKB2 and RELB, encoding proteins that form the non-canonical NF-κB transcription factor. In combination with IL2, D18 treatment is specific for T regs in (1) stabilising NF-κB-inducing kinase protein, the activator of non-canonical NF-κB signalling, (2) inducing translocation of RelB from cytosol to nucleus, (3) increasing cell cycle entry, and (4) increasing cell numbers. However, the regulatory function of the expanded T regs is unaltered. Inhibition of RelB nuclear translocation blocks the proliferative response. We conclude that ligation of TNFR2 by D18 enhances IL2-induced T regs proliferation and expansion in cell number through the non-canonical NF-κB pathway.
人类调节性 T 细胞 (Tregs) 表达高水平的肿瘤坏死因子受体 2 (TNFR2)。TNFR2 与肿瘤坏死因子 (TNF) 的结合,TNF 可以识别 TNFR1 和 TNFR2,或与 TNFR2 选择性结合分子 DARPin18 (D18),激活经典 NF-κB 信号通路,通过 IκBα 降解来评估,并且反应的幅度与 TNFR2 的表达水平相关。TNF 或 D18 处理后的人类 Tregs 的 RNA-seq 分析表明,TNFR2 结合诱导 NFKB2 和 RELB 的转录,编码形成非经典 NF-κB 转录因子的蛋白质。与 IL2 联合使用,D18 处理在以下方面对 Tregs 具有特异性:(1)稳定非经典 NF-κB 信号通路的激活剂 NF-κB 诱导激酶蛋白,(2)诱导 RelB 从细胞质向细胞核易位,(3)增加细胞周期进入,和 (4)增加细胞数量。然而,扩展的 Tregs 的调节功能没有改变。RelB 核易位的抑制阻止了增殖反应。我们得出结论,D18 通过 TNFR2 的结合增强了 IL2 诱导的 Tregs 增殖和数量扩张,通过非经典 NF-κB 途径。